Nicola Squire

Partner
Full contact info

Iā€™m excited to help businesses thrive by finding pragmatic and commercial solutions to their compensation and benefits issues both in the UK and internationally.

Passions

Travel

Reading

Experience

Snyk Acquires Enso Security

June 12, 2023

Cooley advised Snyk, a leader in developer security, on its acquisition of Enso Security, pioneers of the industry’s first application security posture management (ASPM) solution.

Read more

Related contacts

Ben Shribman
Partner, London
Charlotte Irvine
Associate, London
Kerry Corrigan
Associate, London
Leo Spicer-Phelps
Associate, London
Juan Nascimbene
Associate, London
David Wilson
Partner, London
Nicola Squire
Partner, London
Shehzad Akram
Trainee Solicitor , London

Related Practices & Industries

Redx Pharma to Merge With Jounce Therapeutics

March 6, 2023

Cooley advised Redx Pharma, a UK clinical-stage biotechnology company, on its all share merger with Jounce Therapeutics, a US clinical-stage immunotherapy company, in a $425 million and contingent value right transaction.

Related contacts

Michal Berkner
Partner, London
Claire Keast-Butler
Partner, London
Russell Anderson
Associate, London
Rita Sobral
Associate, London
Natasha Kaye
Partner, London
Nicola Squire
Partner, London
Aaron Pomeroy
Partner, Colorado
Megan Browdie
Partner, Washington DC
Caroline Hobson
Partner, London
Paula Holland
Partner, London
David Wilson
Partner, London
Josh Kaufman
Partner, New York
Laurence Harris
Partner, London
Chris Stack
Partner, London
Jeff Goldman
Special Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington DC
Stacey A. Bradford
Special Counsel, Washington DC
Charlotte Irvine
Associate, London
Vlad Herta
Associate, London
Bethan Chalmers
Associate, London
Dov Fiskus
Associate, New York
Amanda Griggs
Associate, New York
Anna Caro
Associate, London
Rick Jantz
Associate, Los Angeles Santa Monica
Dionne A. Thomas
Associate, San Diego

Structure Therapeutics ā€“ $185.3 Million IPO

February 9, 2023

San Francisco – February 9, 2023 Cooley advised Structure Therapeutics, a clinical-stage global biopharmaceutical company, on its $185.3 million initial public offering, including the full exercise of the underwriters’ option to purchase additional American depositary shares. Lawyers Charlie Kim, Patrick Loofbourrow, Andrew Harline and Su Lian Lu led the Cooley team.

The offering marks the first sizable US life sciences IPO this year. Structure Therapeutics will use the proceeds to develop new oral therapies for the treatment of various diseases, including those impacting the metabolic, cardiovascular and pulmonary systems. Its lead product candidate targets Type 2 diabetes and obesity.

Structure Therapeutics aims to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages structure-based drug discovery and computational chemistry expertise, enabling it to build a pipeline of product candidates. The company currently focuses on G-protein-coupled receptors as a therapeutic target class.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.

Related contacts

Charlie Kim
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Andrew Harline
Partner, Singapore
Su Lian Lu
Special Counsel, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Jie Zhang
Partner, Hong Kong
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Carlos Ramirez
Partner, San Diego
Ryan Blair
Partner, San Diego
Joshua Mates
Partner, San Francisco
Mark Ballantyne
Partner, Reston
Nicola Squire
Partner, London
Francis Wheeler
Partner, Colorado
Will Cai
Partner, Hong Kong
Thomas Welk
Senior Counsel, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Dani Nazemian
Special Counsel, San Diego
Randy Sabett
Special Counsel, Washington DC
Bin Wang
Special Counsel, Palo Alto
Rebecca Ross
Special Counsel, Washington DC
Lisa Yuan
Special Counsel, Beijing
Jennifer Shanley
Special Counsel, New York
Christine Turner
Associate, Colorado
Vince Flynn
Associate, San Diego
Ivy Wang
Associate, Shanghai
Rick Jantz
Associate, Los Angeles Santa Monica
Yuan Dai
Associate, Shanghai
Cara Buchicchio
Associate, New York
Megan Drill
Associate, San Diego
Daniel Gillon
Associate, San Diego
Dionne A. Thomas
Associate, San Diego
Cristina Ferruolo
Associate, San Diego
Brian Lau
International Legal Project Manager, Hong Kong
Jessica Wade
Paralegal Specialist, San Diego
Kate Walther
Paralegal Specialist, San Diego
Lunga Su
Associate, Shanghai
Christine S. Kim
Associate, San Diego
Andy Zachrich
Associate, San Diego

Related Practices & Industries

Amryt Pharma to Sell to Chiesi Farmaceutici in $1.48 Billion Cross-Border Transaction

January 9, 2023

Cooley advised Amryt Pharma, a Dublin, Ireland-based commercial-stage biopharmaceutical company, on its definitive agreement to be acquired by Chiesi Farmaceutici, a Parma, Italy-based research-focused biopharmaceuticals and healthcare group, in a $1.48 billion cash and contingent value right (CVR) transaction. Partners Bill Sorabella, Claire Keast-Butler and Bill Roegge led the joint US and UK Cooley team advising Amryt.

Related contacts

Bill Sorabella
Partner, New York
Claire Keast-Butler
Partner, London
Bill Roegge
Partner, New York
Jacqueline Grise
Partner, Washington DC
Christopher Kimball
Partner, Washington DC
Eileen Marshall
Partner, Washington DC
Barbara Mirza
Partner, Los Angeles Santa Monica
Nicola Squire
Partner, London
David Wilson
Partner, London
David Burns
Special Counsel, Washington DC
Christine Graham
Special Counsel, London
Stella Sarma
Special Counsel, Brussels
Joyce Li
Associate, Chicago
Mor Agam
Associate, New York
Karun Ahuja
Associate, Chicago
Russell Anderson
Associate, London
Jack Jones
Associate, London
Pat O'Connell
Associate, New York
Jia Xie
Associate, London
Anthony Hajj
Associate, New York

Related Practices & Industries

2C2P and Ant Group Partner to Accelerate Digital Payment Adoption

April 21, 2022

Cooley advised 2C2P, a global payments platform, on its strategic partnership with Ant Group, an innovative technology provider that strives to bring the world inclusive, green and sustainable services. Lawyers Matthew Bartus and Gwenlynne Lee led the Cooley team advising 2C2P.

Read more

Related contacts

Matthew Bartus
Partner, San Francisco
Gwenlynne Lee
Counsel, Singapore
Xinwei Li
Associate, Singapore
Shu-en Wee
Associate, Singapore
Natasha Kaye
Partner, London
Pearlynn Wang
Associate, Singapore
Jack Jones
Associate, London
Marzia Di Candido
Associate, London
Andrew Harline
Partner, Singapore
Amy Collins
Special Counsel, London
Karen Tsai
Special Counsel, Washington DC
Nicola Squire
Partner, London
Leo Spicer-Phelps
Associate, London
Kristin O'Hanlon
Special Counsel, San Francisco
Rama Padmanabhan
Partner, San Diego
Blake Martell
Partner, San Francisco
Xander Lee
Partner, Los Angeles Santa Monica
Paula Holland
Partner, London
Rachel F. Katz
Associate, New York
Rachel Thorn
Partner, New York
Chris Coulter
Partner, London
Charlotte Lennon
Associate, London
Ajay Athavale
Associate, San Francisco
Yi Jia Ng
Associate, Singapore

Related Practices & Industries

View more

Rankings & accolades

The Legal 500 UK: Employee Share Schemes (2022)

Chambers & Partners UK - Associate to Watch: Employee Share Schemes & Incentives (2022)

Memberships & affiliations

Employment Lawyers Association

Share Plan Lawyers